Skip to main content
XBAP logo
XBAP
(BATS)
Innovator U.S. Equity Accelerated 9 Buffer ETF - April
$42.11-- (--)
Loading... - Market loading

XBAP ETF: Innovator U.S. Equity Accelerated 9 Buffer ETF - April - Price, Holdings & Analysis

Innovator U.S. Equity Accelerated 9 Buffer ETF - April Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$41.94 - $42.05
52-Week High$42.18
52-Week Low$36.85
Open$42.04
Volume1.30K
Average Volume (3M)6.26K
Assets (AUM)133.30M
Expense Ratio0.79%
Total Holdings9
Inception DateMar 31, 2021
1 Day Change-0.16%
1 Month Change0.86%
6 Month Change8.69%
YTD Change8.90%
1 Year Change14.00%
52-Week Change13.86%
5 Year Change59.50%
50-Day MA$41.72
200-Day MA$39.56
RSI52.97
Stochastic %K48.35
Stochastic %D79.43
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Innovator U.S. Equity Accelerated 9 Buffer ETF - April

What is the current price of XBAP?

The latest XBAP price is $41.94. The 52-week range is $36.85–$42.17. XBAP has returned 13.9% over the past 52 weeks.

What is the expense ratio for XBAP?

XBAP's annual expense ratio is 0.79%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Alternative ETFs in the ETF Screener.

Does XBAP pay dividends?

Innovator U.S. Equity Accelerated 9 Buffer ETF - April does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Alternative category.

What are the top holdings of XBAP?

XBAP's largest holdings are Vanguard Index Funds - Vanguard S&P 500 ETF (83.3%), Vanguard S&P 500 ETF (82.5%) (combined weight: 165.8%). The fund holds 9 total positions. View the complete portfolio breakdown in the Holdings section.

How does XBAP compare to similar ETFs?

Compare XBAP (0.79% expense ratio, $133M AUM) against similar Alternative ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.